VC MONITOR: MEDTECH
by New Harbor Venture Partners, April 22, 2024
We raise capital from the top VCs within the life science-dedicated investment community, globally, and represent their portfolio companies. The VC Monitor: MedTech highlights the information we find interesting and use daily. Please hit the subscribe button (above), and share.
VENTURE DEALS
Summaries. Company. Deal size, round. Therapeutic area / vertical. Lead / select investors. Location. Each linked to related article and / or website.
CONFERENCE AND EVENT CALENDAR
APRIL
MAY
JUNE
NOT FOR PROFIT - MAKING CONNECTIONS
SELECT HEADLINES
M&A and EXITS
NEW FUNDS
FDA & REGULATORY
MORE NOTES AND NEWS
PODS
FUNDING AND FUNDS
AI
MORE PODS
ENTREPRENUERS AND EARLY STAGE
LIFE SCIENCE - BIOTECH
DATA AND RESEARCH
Now available from PitchBook: "Recapping the 2024 Eyecelerator @ ASCRS Conference": "VC investment in ophthalmology has ebbed and flowed in recent years, although deal volume declines have been more pronounced in higher-risk biopharma than in ophthalmic medical devices. Deal activity for 2024 is off to a strong start so far with more than $470 million in Q1, more than doubling the last quarter’s figure."
NEW HARBOR VENTURE PARTNERS
Disclaimer
This site and the information provided herein is for informational purposes only, and no investment, tax, legal, insurance advice is intended or given. Nothing on this site should be construed to be (i) an offer to sell or a solicitation to purchase a security, or (ii) a recommendation regarding any security. Information in videos, articles, and blog posts on this site that discuss specific securities is general in nature, is not tailored to the investment needs of any particular person, and should not be relied upon without independent verification. Information in videos, articles, and blog posts on this site may affect the market prices of the securities discussed. Investment decisions are subject to certain risk factors that may not be discussed completely, or at all, on this site. All investing involves risk. We believe that any performance data provided on this site is provided from sources we deem to be reliable; however, we do not guarantee the accuracy or completeness of any such data and make no assurances with respect to results to be obtained from their use. You should verify any such data through your own sources. Your Investment decisions and strategies should be determined solely by you in the exercise of your own judgment based on your unique investment objectives and financial circumstances. Carefully consider the investment objectives, risks, charges and expenses of any investment company before investing. If you need professional advice, you should consult your own professional advisors. We do not independently verify, nor do we seek independent verification of comments and statements that may be posted by others in blog or social media posts on this site or affiliated social media sites regarding our website, its products or services. For this reason, if others post "success story" or "best-case" scenario testimonials (as distinguished from subjective opinions), you should assume that their results are NOT typical.